Titel

Merkliste
1 Ergebnisse

2DR initiation:

Daniel David (594568) ; Eynat Kedem (786470) ; Dan Turner (240679)...
https://figshare.com/articles/figure/2DR_initiation_/16905891. , 2021

Link: https://doi.org/10.1371/journal.pone.0259271.g001

RT Journal
T1 <Title>2DR initiation</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_16905891&Exemplar=1&LAN=DE
				
A1 Daniel David (594568)
A1 Eynat Kedem (786470)
A1 Dan Turner (240679)
A1 Itzchak Levy (364292)
A1 Daniel G. Elbirt (11624886)
A1 Eduardo Shahar (384539)
A1 Valery Istumin (11624889)
A1 Orna Mor (3297237)
A1 Michal Chowers (384546)
A1 Hila Elinav (515355)
YR 2021
K1 Cell Biology
K1 Pharmacology
K1 Biotechnology
K1 Evolutionary Biology
K1 Developmental Biology
K1 Cancer
K1 Infectious Diseases
K1 Virology
K1 viral suppression improvement
K1 suppressing hiv viremia
K1 major reasons leading
K1 main reason leading
K1 israeli patients treated
K1 wide survey proved
K1 xlink "> characterize
K1 three antiretroviral medications
K1 potential treatment option
K1 xlink "> 2dr
K1 xlink ">
K1 sectional survey
K1 recommended option
K1 treatment simplification
K1 traditionally consists
K1 metabolic parameters
K1 mean cd4
K1 life setting
K1 following 24
K1 elevating cd4
K1 drug resistance
K1 drug regimens
K1 clinical efficacy
K1 cell increase
K1 adverse effects
K1 2dr use
K1 2dr treatment
K1 2dr switching
K1 2dr induced
K1 144 weeks
K1 004 )
JF https://figshare.com/articles/figure/2DR_initiation_/16905891
LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0259271.g001
DO https://doi.org/10.1371/journal.pone.0259271.g001
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)